Teruko Osumi

3JC48-3 (methyl 4′-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1′-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growth

S. Shukla, S. Fletcher, Y. Mackeyev, 2022, Cancer Gene Therapy.

The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth

S. Shukla, S. Fletcher, J. Copland, 2023, Cancers.